Stacey Akers, MD

PrintE-mail
Staff Physician
Roswell Park Cancer Institute

Research

Research Interests: 
Pharmacology and Therapeutics Research - Association between global DNA hypomethylation in leukocytes and ovarian cancer risk

Background Information

Education and Training: 
MD - University of South Alabama College of Medicine, Mobile, AL
Birmingham-Southern College, Birmingham, AL
Residency: 
University of Louisville, Louisville, KY
Board Certification: 
ABOG written board: Passed June 2007; Active Candidate
Fellowships: 
Roswell Park Cancer Institute, Buffalo, NY
University of Texas MD Anderson Cancer Center, Houston, TX
Honors and Awards: 
Cancer Education Consortium - Awarded to 25 Oncology Fellows Annually
CREOG Award
Dean's List - University of South Alabama College of Medicine
Excellence in Clinical Research - Awarded to 60 Obstetrics and Gynecology Fellows Annually
Golden Hands Award - Awarded to Resident with Best Surgical Skills
Honors Pathology - Awarded to Top 10 Percent of Medical Students
Merck Manual Award - Competitive Medical School Academic Scholarship
Resident’s Research Day Award - Awarded to Top Senior Resident Research Project
Russell Memorial Scholarship - Competitive Medical School Academic Scholarship
Waterman Scholarship - Competitive Medical School Academic Scholarship
Professional Memberships: 
American Congress of Obstetricians and Gynecologists, Junior Fellow
American Medical Association
Jefferson County Medical Association
Kentucky Medical Association
Society of Gynecologic Oncologists, Junior Fellow

Publications

Publications: 
  • Akers SN, Odunsi K, Karpf AR. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. Future oncology (London, England) 2010; 6(5):717-732
  • Akers S, Moysich K, Zhang W, Link P, Miller A, Lele S, Odunsi K, Karpf A. Association between global DNA hypomethylation in leukocytes and risk of ovarian cancer. Gynecologic oncology 2011; 121(1 Suppl.):100
  • Kesterson J, Wang D, Akers S, duPont N, Clark K, Lele S, Liu S, Mhawech-Fauceglia P. The transforming growth factor beta signaling pathway in endometrial cancer: Expression and clinical significance. Gynecologic oncology 2011; 121(1 Suppl.):223
  • Woloszynska-Read A, Odunsi K, Godley LA, Ostler KR, Akers SN, Collamat G, Mhawech-Fauceglia P, Link PA, Yu J, Zhang W, Karpf AR. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clinical cancer research 2011; 17(8):2170-2180
  • Mhawech-Fauceglia P, Kesterson J, Wang D, Akers S, Dupont NC, Clark K, Lele S, Liu S. Expression and clinical significance of the transforming growth factor-beta signalling pathway in endometrial cancer. Histopathology 2011; 59(1):63-72
  • Riebandt G, Rodabaugh KJ, Pietkiewicz J, Fong MK, Groman AE, Lele SB, Odunsi K, Akers S. Prospective analysis of chemotherapy-induced neuropathy in patients with gynecologic malignancies : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e19737
  • Akers S, Khulpateea B, Groman A, Kesterson J, Odunsi K, Lele S, Frederick P. Adjuvant treatment for uterine leiomyosarcoma. Gynecologic oncology 2012; 125(Suppl. 1):S159